Please login to the form below

Not currently logged in
Email:
Password:

Lucid Group names Neil Flash chief commercial officer

Flash joins the team from dna Communications

Neil Flash

Lucid Group has appointed Neil Flash as its new chief commercial officer, who joins from dna Communications.

In his previous role at dna, Flash served as EMEA managing director for six years. As managing director, he was responsible for the company’s brand proposition across the EMEA region, as well as the expansion of its client partner portfolio.

Prior to joining dna, he spent over five years at each of Huntsworth Health, Virgo and Cohn & Wolfe.

Flash has spent much of his career working for a number of major pharmaceutical and life sciences companies.

He has represented brands across each stage of the lifecycle, helping client partners to navigate the evolving healthcare sector across the UK, EMEA, Asia Pacific and global locations.

In addition to his career experience, Flash has a scientific background gained from a degree in BioMedical Science from Portsmouth University.

He has also been part of numerous award-winning teams, including those which have won agency award from Communiqué, Holmes Report and PRWeek. In addition, he has worked on award-winning campaigns recognised by Communiqué, PM Society and PR Week, and is a regular Communiqué judge.

“Neil is an exceptional communications professional and a talent we have admired for some time. His balance of commercial strategy, business and people focus make him a perfect fit for Lucid as he leads a core part of our business,” said Dennis O’Brien, Lucid Group CEO.

Article by
Lucy Parsons

22nd January 2020

From: Marketing

Share

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Cuttsy + Cuttsy

How do you understand what patients really need, without actually living their lives? How do you walk in someone else’s...

Latest intelligence

What’s in it for me? How to engage, motivate and support staff with internal training at OPEN Health
...
Environmental impact of in-person vs. virtual meetings
Although it will be tempting to resume in-person activities in the same capacity as before, we need to weigh the pros and cons of virtual vs. in-person vs. hybrid events...
US biosimilars
The US celebrates five years of biosimilars on the market – a look to the past, present and future
Why the success of biosimilars in the US has been mixed...

Infographics